Dr. Patel on Sequencing Therapy in Rectal Cancer

Timil Patel, MD
Published: Wednesday, Nov 27, 2019



Timil Patel, MD, clinical fellow in Hematology/Oncology, Yale School of Medicine, discusses an optimal sequencing strategy in rectal cancer.
 
Following chemotherapy, patients are restaged, and a multidisciplinary tumor board recommends next steps based on the patient’s response to systemic chemotherapy, says Patel.
 
Generally, chemoradiation is recommended for patients with a single site of disease who responded well to chemotherapy. Subsequently, a tumor board will decide whether radiation or surgical resection is the optimal approach to treat lung nodules, concludes Patel.
SELECTED
LANGUAGE


Timil Patel, MD, clinical fellow in Hematology/Oncology, Yale School of Medicine, discusses an optimal sequencing strategy in rectal cancer.
 
Following chemotherapy, patients are restaged, and a multidisciplinary tumor board recommends next steps based on the patient’s response to systemic chemotherapy, says Patel.
 
Generally, chemoradiation is recommended for patients with a single site of disease who responded well to chemotherapy. Subsequently, a tumor board will decide whether radiation or surgical resection is the optimal approach to treat lung nodules, concludes Patel.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication
x